Today’s AI Top Pick: PODD

7/15/2026 · Recently Alerted GARP screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · PODD80%164 resolved forecasts · 45d window · verify →

Today's pick · Recently Alerted GARPPODDBUY NOW8.6 / 107/15/2026

Insulet (PODD) offers the cleanest combination of GARP fundamentals, multi-timeframe forecast alignment, and a supportive news backdrop in this pool. Fundamentally it clears the screen with room to spare: PEG 0.74, fwdPe 19.76, epsNextY +24.37%, salesYoY +31.93%, ROE 23%, profit margin 10.44%, analyst recom 1.43 and targetUpsidePct 46.8. Institutional ownership at 104.99% signals conviction from the biggest holders even after a brutal drawdown (perfYear -45.51%, perfYtd -44.02%). The tape now confirms rather than fights the thesis. Daily forecast is +23.06% short / +65.54% mid / +64.98% long with dd_from_21bar_high only -3.26% and pos_in_21bar_range at 78.99 — buying strength but not at the extreme. 4h forecast climbs from -4.91% short to +20.04% mid and +53.56% long, and the weekly picture is even more constructive at +10.93 / +34.54 / +53.15 with a deep -35.48% drawdown from the 21-bar high (huge upside room). Bullish_prob is 1.0 and near_term_bullish is 1.0. Only the 1h is mildly soft (fc_mid -4.4%), which just means a mild intraday dip is possible on entry, not a broken structure. Why today over waiting: the daily/weekly forecasts are the biggest in this pool for a stock that ALSO has real profitability and screening-quality fundamentals (unlike HSAI at 279x PE or ADMA whose weekly forecast is nearly flat). The recent 7/14 partnership news with Calm is a neutral-to-positive brand catalyst and there is nothing negative in the tape — no DOJ probe (FUTU), no COO insider sales (SE), no guidance cut (CRK), no dilution risk flagged. Bottom line: cleaner setup than FUTU (which has a DOJ probe and class actions — automatic disqualification for #1) and ORCL (RSI 25.5 and weekly forecast still negative). PODD is the buy.

Entry zone

$155–$160 (near current $159.12; scale in on any 1h dip toward $155 given fc_short_1h of -8.13%)

Stop loss

$146 (below the recent 21-bar daily consolidation and ~8% risk from entry)

First target

$180 (roughly +13%, aligns with 4h fc_mid +20% zone and clears the immediate overhead)

Longer target

$220–$240 (+38–50%, tracks the 1d fc_mid/long +65% and the analyst targetUpsidePct 46.8%)

Risks

PODD has already round-tripped -45.51% over the last year — sentiment can stay negative and the -35.48% weekly drawdown means overhead supply is real
1h forecast is negative (fc_short -8.13%, fc_mid -4.4%) so a near-term shakeout to $150–$155 is plausible before the daily setup plays out
pos_in_21bar_range on 1d is 78.99 — not a bottom entry, so a broader tape sell-off could pull it back sharply
Insulin pump competition (Tandem, Medtronic 780G) could pressure the +31.93% sales growth pace; a guidance cut would break the thesis
fwdPe 19.76 is reasonable but profit margin 10.44% is thin — any margin miss gets punished hard given the recent perf history

Honorable mentions

ADMABest forecast magnitude in the pool (1d fc mid +88.1%, long +74.49%) with cheap fundamentals (PEG 0.32, fwdPe 9.21, ROE 43.3, profit margin 32.4%) and 100% analyst upside. Downgraded from #1 because the 1wk forecast is nearly flat (+0.72% mid) and short float 10.76% raises squeeze/whip risk. Positive Simply Wall St. undervaluation note supports the bull case.

DCBOMassive weekly forecast (+81.59% mid / +93.27% long) with peg 0.45, ROE 132.85, fwdPe 9.21. Held back from #1 because 1h/4h short forecasts are negative and pos_in_21bar_range on 1d is 93.87 — chasing risk in the very near term. Better as a pullback buy toward $17.50.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	PODD	BUY NOW	8.6	Clean multi-tf alignment, +65% mid-term daily forecast, GARP-quality fundamentals and positive news — best risk/reward today.
2	ADMA	BUY NOW	8.2	Biggest daily forecast (+88% mid) with PEG 0.32 and 43% ROE; weekly forecast tepid but daily setup is elite.
3	DCBO	BUY PULLBACK	7.7	Weekly forecast +81% mid on peg 0.45 and ROE 132, but at 93rd percentile of range — wait for a dip.
4	HSAI	BUY NOW	7.4	1d forecast +44% long, salesYoY 44.14%, epsNextY 73.29% and pos_in_range only 25 — momentum with room, though PE 279 is a valuation asterisk.
5	BILI	BUY NOW	7.1	1d fc +48.82% mid with PEG 0.52, recent $300M buyback authorization and analyst recom 1.30.
6	PDD	BUY NOW	6.7	PEG 0.61, fwdPe 6.8, profit margin 21.86% — cheapest quality name, though Shein IPO headlines add competitive noise.
7	NOW	BUY PULLBACK	6.4	1d fc +22.98% mid and near_term_bullish 1.0, but 1h/4h forecasts negative — patient entry preferred.
8	HURN	BUY PULLBACK	6.3	1d fc +31.85% mid and analyst recom 1.00, but pos_in_range 92.9 says wait for a dip.
9	MLCO	BUY NOW	6.2	Weekly fc +44%/+53% mid/long with fwdPe 7.11 and peg 0.26; ‘worst is behind us’ tape supports the turn.
10	CALX	BUY PULLBACK	6.1	1d fc +34% mid and pre-earnings positive; PE 80 and pos_in_range 88 argue for waiting on the print.
11	NRDS	BUY NOW	6.0	PEG 0.27, fwdPe 8.18 and 1wk fc_long +28.48%, though a recent SeekingAlpha downgrade cuts the confidence.
12	PFSI	BUY NOW	5.9	fwdPe 6.05, peg 0.32, near_term_bullish 1.0 — Barclays downgrade is a mild drag.
13	SRAD	BUY PULLBACK	5.7	1d fc +33.66% long and near_term_bullish 1.0, but 1h forecast is negative and 4h at 0-percentile of range.
14	MSFT	WAIT	5.5	Cleanest quality name (ROE 34, margins 39%) but weekly forecast is negative (fc_long -3.68%) — no urgency.
15	ONON	BUY PULLBACK	5.4	1wk fc +15%/+18%/+11% and salesYoY 36%, but 1h/4h/1d near-term all soft; wait for consolidation.
16	SMCI	WAIT	5.3	1d fc +28% mid, but recom 3.0 (Hold), thin margins 3.7%, short float 18.5% and drawdown -39% weekly — messy.
17	KKR	WAIT	5.2	Fundamentals fine (salesYoY 35.81%) but pos_in_range 100 on 1h/4h and weekly forecast negative — chasing risk.
18	SAP	WAIT	5.1	PEG 0.97, fwdPe 15.81 and targetUpside 60.6%, but no forecast-magnitude edge here today.
19	FRSH	WAIT	5.0	1d fc positive and PEG 1.05, but bullish_prob only 0.6 and near_term_bullish 0.6 — signal ambiguous.
20	STEP	WAIT	5.0	salesYoY 69.89% and 1d fc +34% long, but negative operating margin -45.64% and ROE -750 make it high-risk despite the screen pass.
21	ORCL	BUY PULLBACK	4.9	RSI 25.5 and 1d fc +54% mid look enticing, but 1wk forecast still negative and near_term_bullish 0 — knife-catch risk.
22	SE	AVOID	4.6	RSI 69.6, pos_in_range 90 and COO Gang Ye unloading $4.5M in stock this week — bad tape and bad signal.
23	TOST	AVOID	4.5	Pos_in_range 100 across every timeframe, RSI 67.86 and forecasts negative short-term — textbook chase setup to avoid.
24	FUTU	AVOID	4.3	DOJ probe and US class actions announced 7/3 — regardless of the +47.83% 1d fc, headline risk disqualifies as a today buy.
25	CRK	AVOID	4.2	1wk fc_long -13.83%, StockStory ‘cash-burning/questionable fundamentals’ flag and short float 28.93% — high-risk combo.
26	AGI	AVOID	4.0	Weekly fc -37% mid / -53% long with -45% drawdown — forecast tape says this leg is not done.
27	EQX	AVOID	3.9	1wk fc -30%/-39% mid/long and pos_in_range 0 — falling knife despite peg 0.19.
28	DRD	AVOID	3.8	Gold-miner cohort under weekly-forecast pressure; 1d fc mid +20% but timeframe agreement is poor.
29	GAU	AVOID	3.7	Weekly fc -14%/-21%/-39% with -49% drawdown — momentum broken.
30	ITRG	AVOID	3.6	Weekly fc -15%/-23%/-38% and pos_in_range 0 — despite peg 0.11 and 184% salesYoY, tape is against it.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord